T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue

Journal of Virology

Volumn 85, Issue 7, 2011, Pages 3664-3676

  Stubblefield Park, Samantha R ^a   Widness, Mi ^a,b   Levine, Alan D ^a   Patterson, Catherine E ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 18; JANUS KINASE; NEUTRALIZING ANTIBODY; RANTES; RECOMBINANT GAMMA INTERFERON; STAT PROTEIN; VIRUS RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; BRAIN TISSUE; CD3+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; IMMUNOCOMPETENCE; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION INHIBITION; LYMPHOCYTE FUNCTION; MEASLES; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS LOAD; VIRUS SURVIVAL; WEST NILE FLAVIVIRUS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; MEASLES; MEASLES VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN CULTURE TECHNIQUES; T-LYMPHOCYTES; VIRAL LOAD;

MEASLES VIRUS; MUS;

EID: 79952581361     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01496-10     Document Type: Article

References (86)

1. Abbott, A. 2003. Cell culture: biology's new dimension. Nature 424:870-872. (Pubitemid 37051657)
2. Abrignani, S. 1997. Bystander activation by cytokines of intrahepatic T cells in chronic viral hepatitis. Semin. Liver Dis. 17:319-322.
3. Arpino, C., et al. 2002. Reactivation of human herpesvirus 6 infection in an immunocompetent host with chronic encephalopathy. J. Infect. Dis. 185:1843-1844.
4. Becher, B., B. G. Durell, and R. J. Noelle. 2003. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 112:1186-1191.
5. Bergmann, C. C., C. Ramakrishna, J. M. Gonzales, S. I. Tschen, and S. A. Stohlman. 2006. Coronavirus immunity: from T cells to B cells. Adv. Exp. Med. Biol. 581:341-349.
6. Berlin, A. A., C. M. Hogaboam, and N. W. Lukacs. 2006. Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Lab Invest. 86:557-565.
7. Billiau, A., et al. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 140:1506-1510.
8. Binder, G. K., and D. E. Griffin. 2003. Immune-mediated clearance of virus from the central nervous system. Microbes Infect. 5:439-448.
9. Binder, G. K., and D. E. Griffin. 2001. Interferon-gamma-mediated sitespecific clearance of alphavirus from CNS neurons. Science 293:303-306.
10. Bluyssen, A. R., J. E. Durbin, and D. E. Levy. 1996. ISGF3 gamma p48, a specificity switch for interferon activated transcription factors. Cytokine Growth Factor Rev. 7:11-17.
11. Bossolasco, S., et al. 1999. Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance. J. Neurol. Neurosurg. Psychiatry 67:789-792.
12. Brooks, D. G., et al. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12:1301-1309.
13. Burdeinick-Kerr, R., D. Govindarajan, and D. E. Griffin. 2009. Noncytolytic clearance of Sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J. Virol. 83:3429-3435.
14. Burdeinick-Kerr, R., J. Wind, and D. E. Griffin. 2007. Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J. Virol. 81:5628-5636.
15. Cannon, M. J. 2009. Congenital cytomegalovirus (CMV) epidemiology and awareness. J. Clin. Virol. 46(Suppl. 4):S6-S10.
16. Carr, D. J., J. Chodosh, J. Ash, and T. E. Lane. 2003. Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J. Virol. 77:10037-10046.
17. Christen, U., D. B. McGavern, A. D. Luster, M. G. von Herrath, and M. B. Oldstone. 2003. Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand [CXCL] 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J. Immunol. 171:6838-6845.
18. Christensen, J. E., et al. 2009. Fulminant lymphocytic choriomeningitis virus-induced inflammation of the CNS involves a cytokine-chemokine- cytokinechemokine cascade. J. Immunol. 182:1079-1087.
19. Constantinescu, C. S., et al. 2005. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23. J. Neurochem. 95:331-340. (Pubitemid 41457502)
20. Coutelier, J. P., J. Van Broeck, and S. F. Wolf. 1995. Interleukin-12 gene expression after viral infection in the mouse. J. Virol. 69:1955-1958.
21. Debiasi, R. L., and K. L. Tyler. 2004. Molecular methods for diagnosis of viral encephalitis. Clin. Microbiol. Rev. 17:903-925.
22. Diggle, P. J., K.-Y. Liang, and S. L. Zeger (ed.). 1994. Analysis of longitudinal data, vol. 13. Oxford University Press, New York, NY.
23. Duprex, W. P., S. McQuaid, L. Hangartner, M. A. Billeter, and B. K. Rima. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 73:9568-9575.
24. Ehrengruber, M. U., et al. 1999. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc. Natl. Acad. Sci. U. S. A. 96:7041-7046.
25. Glass, W. G., et al. 2004. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 172:4018-4025. (Pubitemid 38375213)
26. Gray, F., et al. 1996. Neuropathology of early HIV-1 infection. Brain Pathol. 6:1-15. (Pubitemid 26078651)
27. Gremion, C., and A. Cerny. 2005. Hepatitis C virus and the immune system: a concise review. Rev. Med. Virol. 15:235-268.
28. Guidotti, L. G., et al. 1999. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J. Exp. Med. 189:1555-1564.
29. Gyorkey, F., J. L. Melnick, and P. Gyorkey. 1987. Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J. Infect. Dis. 155:870-876.
30. Horvath, C. M. 2000. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem. Sci. 25:496-502.
31. Howell, M. D., et al. 2006. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24:341-348.
32. Kamal, S. M., and K. El Sayed Khalifa. 2006. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol. 28:483-496. (Pubitemid 44370854)
33. Katayama, Y., H. Hotta, A. Nishimura, Y. Tatsuno, and M. Homma. 1995. Detection of measles virus nucleoprotein mRNA in autopsied brain tissues. J. Gen. Virol. 76(Pt. 12):3201-3204.
34. Katayama, Y., et al. 1998. Detection of measles virus mRNA from autopsied human tissues. J. Clin. Microbiol. 36:299-301.
35. Kimberlin, D. W. 2007. Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment. Herpes 14:11-16. (Pubitemid 47235458)
36. Klein, R. S., et al. 2005. Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466. (Pubitemid 41170686)
37. Lawrence, D. M., M. M. Vaughn, A. R. Belman, J. S. Cole, and G. F. Rall. 1999. Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J. Virol. 73:1795-1801.
38. Li, J., Y. Liu, and X. Zhang. 2010. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J. Virol. 84:6472-6482.
39. Li, Y., et al. 2008. Inducible IL-23p19 expression in human microglia via p38 MAPK and NF-kappaB signal pathways. Exp. Mol. Pathol. 84:1-8.
40. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.
41. Manchester, M., and G. F. Rall. 2001. Model systems: transgenic mouse models for measles pathogenesis. Trends Microbiol. 9:19-23.
42. Marques, C. P., S. Hu, W. Sheng, and J. R. Lokensgard. 2006. Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res. 121:1-10.
43. Matsumoto, M., et al. 1999. Activation of the transcription factor ISGF3 by interferon-gamma. Biol. Chem. 380:699-703.
44. McCandless, E. E., B. Zhang, M. S. Diamond, and R. S. Klein. 2008. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc. Natl. Acad. Sci. U. S. A. 105:11270-11275.
45. Meurs, E., et al. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390.
46. Michael, B. D., et al. 2010. Acute central nervous system infections in adults - a retrospective cohort study in the NHS North West region. QJM 103:749-758.
47. Munier, M. L., and A. D. Kelleher. 2007. Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol. Cell Biol. 85:6-15.
48. Nickerson, C. A., E. G. Richter, and C. M. Ott. 2007. Studying host-pathogen interactions in 3-D: organotypic models for infectious disease and drug development. J. Neuroimmune Pharmacol. 2:26-31.
49. Norrby, E., and K. Kristensson. 1997. Measles virus in the brain. Brain Res. Bull. 44:213-220.
50. Novelli, F., and J. L. Casanova. 2004. The role of IL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev. 15:367-377.
51. Novy, P., M. Quigley, X. Huang, and Y. Yang. 2007. CD4 T cells are required for CD8 T cell survival during both primary and memory recall responses. J. Immunol. 179:8243-8251.
52. O'Brien, L. E., M. M. Zegers, and K. E. Mostov. 2002. Opinion: building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell Biol. 3:531-537.
53. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFNalphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746-4756.
54. Oxenius, A., U. Karrer, R. M. Zinkernagel, and H. Hengartner. 1999. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:965-973. (Pubitemid 29035422)
55. Parra, B., D. R. Hinton, M. T. Lin, D. J. Cua, and S. A. Stohlman. 1997. Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 233:260-270.
56. Pasquetto, V., L. G. Guidotti, K. Kakimi, M. Tsuji, and F. V. Chisari. 2000. Host-virus interactions during malaria infection in hepatitis B virus transgenic mice. J. Exp. Med. 192:529-536.
57. Patterson, C. E., J. K. Daley, L. A. Echols, T. E. Lane, and G. F. Rall. 2003. Measles virus infection induces chemokine synthesis by neurons. J. Immunol. 171:3102-3109.
58. Patterson, C. E., J. K. Daley, and G. F. Rall. 2002. Neuronal survival strategies in the face of RNA viral infection. J. Infect. Dis. 186(Suppl. 2):S215-S219.
59. Patterson, C. E., D. M. Lawrence, L. A. Echols, and G. F. Rall. 2002. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J. Virol. 76:4497-4506.
60. Patterson, J. B., D. C. Thomis, S. L. Hans, and C. E. Samuel. 1995. Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210:508-511.
61. Rall, G. F. 2003. Measles virus 1998-2002: progress and controversy. Annu. Rev. Microbiol. 57:343-367.
62. Rall, G. F., et al. 1997. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. U. S. A. 94:4659-4663.
63. Ransohoff, R. M., A. Glabinski, and M. Tani. 1996. Chemokines in immunemediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7:35-46. (Pubitemid 27202664)
64. Richter, K., J. Hausmann, and P. Staeheli. 2009. Interferon-gamma prevents death of bystander neurons during CD8 T cell responses in the brain. Am. J. Pathol. 174:1799-1807.
65. Rodriguez-Galán, M. C., J. H. Bream, A. Farr, and H. A. Young. 2005. Synergistic effect of IL-2, IL-12, and IL-18 on thymocyte apoptosis and Th1/Th2 cytokine expression. J. Immunol. 174:2796-2804.
66. Rossi, M. I., et al. 2005. Multicellular spheroids of bone marrow stromal cells: a three-dimensional in vitro culture system for the study of hematopoietic cell migration. Braz. J. Med. Biol. Res. 38:1455-1462.
67. Rottenberg, M., and K. Kristensson. 2002. Effects of interferon-gamma on neuronal infections. Viral Immunol. 15:247-260.
68. Savarin, C., and C. C. Bergmann. 2008. Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr. Opin. Pharmacol. 8:472-479.
69. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferongamma: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75:163-189.
70. Smith, A. L., S. W. Barthold, M. S. de Souza, and K. Bottomly. 1991. The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM. Arch. Virol. 121:89-100.
71. Song, A., T. Nikolcheva, and A. M. Krensky. 2000. Transcriptional regulation of RANTES expression in T lymphocytes. Immunol. Rev. 177:236-245.
72. Stoppini, L., P. A. Buchs, and D. Muller. 1991. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37:173-182.
73. Tau, G., and P. Rothman. 1999. Biologic functions of the IFN-gamma receptors. Allergy 54:1233-1251.
74. Taylor, S. S., N. M. Haste, and G. Ghosh. 2005. PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking. Cell 122:823-825. (Pubitemid 41345196)
75. Tervo, T., et al. 1986. Abnormal ocular motility as early sign of CNS involvement in HIV infection. Lancet ii:512.
76. Thompson, J. E., et al. 2002. Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg. Med. Chem. Lett. 12:1219-1223.
77. Tiacci, E., et al. 2000. Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor. Haematologica 85:94-97. (Pubitemid 30096898)
78. Tishon, A., M. Eddleston, J. C. de la Torre, and M. B. Oldstone. 1993. Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. Virology 197:463-467.
79. Tishon, A., H. Lewicki, G. Rall, M. Von Herrath, and M. B. Oldstone. 1995. An essential role for type 1 interferon-gamma in terminating persistent viral infection. Virology 212:244-250.
80. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14:335-338. (Pubitemid 23198164)
81. Tsunoda, I., T. Tanaka, and R. S. Fujinami. 2008. Regulatory role of CD1d in neurotropic virus infection. J. Virol. 82:10279-10289.
82. van den Pol, A. N. 2006. Viral infections in the developing and mature brain. Trends Neurosci. 29:398-406. (Pubitemid 44177521)
83. Verbeke, G. (ed.). 1997. Linear mixed models in practice: an SAS-oriented approach, vol. 126. Springer-Verlag New York, LLC, New York, NY.
84. Verjans, G. M., et al. 2007. Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 104:3496-3501.
85. Wang, T., et al. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10:1366-1373.
86. Zhang, S. 2004. Beyond the petri dish. Nat. Biotechnol. 22:151-152.